治疗伴随性喘和支气管切除症患者的挑战
Mario Cazzola1, Luigino Calzetta2, Maria Gabriella Matera3
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Respiratory medicine
|January 23, 2025
概括
管理重叠性喘和支气管切除症需要个性化护理. 吸入性皮质类固醇需要对感染风险进行监测,而类固醇和三重疗法等疗法显示出有前途,但需要更多的研究.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床管理 临床管理
背景情况:
- 喘和支气管切除症经常同时存在,这带来了复杂的管理挑战.
- 目前的治疗策略需要仔细考虑个体患者的个人资料和潜在的药物副作用.
研究的目的:
- 为患有重叠喘和支气管切除症的患者制定量身定制的治疗方法.
- 审查当前和潜在的治疗选择,包括吸入性皮质类固醇,类固醇,LTRA和三重疗法.
主要方法:
- 对喘严重程度和支气管切除症程度的综合临床评估.
- 评估吸入性皮质类固醇 (ICS),类固醇,白三烯受体对抗剂 (LTRA) 和长效肌抗剂 (LAMA) /长效β-agonists (LABA) 疗法.
- 考虑预防措施,如疫苗接种和唾液培养等.
主要成果:
- 吸入性皮质类固醇 (ICS) 是常见的,但需要对感染风险进行监测;如果稳定,可能可以减少剂量.
- 辅助疗法,如宏类和LTRAs (谨慎使用) 可能会带来好处.
- 三重疗法 (ICS/LABA/LAMA) 显示出支气管扩张和炎症减轻的潜力,尽管支气管切开症的RCT证据正在等待.
结论:
- 个性化管理,包括仔细的药物选择和监测至关重要.
- 预防策略对于最小化感染风险至关重要.
- 需要进一步的随机对照试验 (RCT) 来确认先进疗法的有效性,包括三重疗法,在这个患者群体中.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
176
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
176
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139


